Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dual Targeting EZH 2 and Histone Deacetylases in Human Uterine Sarcoma Cells Under Both 2 D and 3 D Culture Conditions

Journal of Cellular and Molecular Medicine(2025)10.1111/jcmm.70626Source: DataRank Database

Dual Targeting EZH 2 and Histone Deacetylases in Human Uterine Sarcoma Cells Under Both 2 D and 3 D Culture Conditions is a research paper published in Journal of Cellular and Molecular Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.80)OA: goldTopics (36)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Somayeh Vafaei ORCID,Samar Alkhrait ORCID,Qiwei Yang ORCID,Ayman Al‐Hendy ORCID,Mervat M. Omran ORCID

Live enrichment

PubMed:40464712 PMC:PMC12135698 OpenAlex:https://openalex.org/W4411045187

National Institutes of Health

Grant: RO1 HD106285

FWCI

0.80

Citation Percentile

0.7%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jcmm.70626

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jcmm.70626

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.70626

journalhttps://doi.org/10.1111/jcmm.70626

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40464712

Fields of Study

Histone Deacetylase Inhibitors ResearchEpigenetics and DNA MethylationCancer-related gene regulation

MeSH Terms

Enhancer of Zeste Homolog 2 ProteinBenzamidesBiphenyl CompoundsCell CycleDioxolesFemaleHistone DeacetylasesHumansMorpholinesPyridinesPyridonesSarcomaUterine NeoplasmsGene Expression Regulation, NeoplasticApoptosisCell Culture TechniquesCell Line, TumorCell ProliferationHistone Deacetylase Inhibitors

Keywords

MedicineCancer researchCell culturePharmacologyCell cycleHistone deacetylaseCancerInternal medicineBiologyHistoneBiochemistryHdac InhibitorsUterine SarcomaEzh2 Inhibitors

Sustainable Development Goals

SDG 0: Good health and well-being